Innoviva (INVA) Capital Expenditures (2010 - 2026)

Innoviva's (INVA) quarterly Capital Expenditures came in at $492000.0 in Q1 2026, down 56.11% on a QoQ basis from $1.1 million in Q3 2025.

Innoviva (INVA) Capital Expenditures (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 14 years of Capital Expenditures data on file, last reported at $492000.0 in Q1 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $492000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 597.41% YoY) and the FY2025 annual result came in at $1.1 million, up 318.89% from the prior year.
  • Capital Expenditures eased to $492000.0 in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.1 million in Q3 2025 to a low of $9000.0 in Q1 2022.
  • A 5-year average of $278875.0 and a median of $146500.0 in 2022 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2023 — Capital Expenditures soared 687.88% — and 2024, when it increased 3.85%.
  • Tracing INVA's Capital Expenditures over 5 years: stood at $33000.0 in 2022, then soared by 687.88% to $260000.0 in 2023, then advanced by 3.85% to $270000.0 in 2024, then soared by 315.19% to $1.1 million in 2025, then slumped by 56.11% to $492000.0 in 2026.
  • The last three Capital Expenditures figures came in at $492000.0 (Q1 2026), $1.1 million (Q3 2025), and $270000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.29 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 572,662.23
7 Royalty Pharma 33.72 Bn 35.84 Bn - 251.02 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 34.68 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.26 Mn
10 Innoviva 1.54 Bn 968.79 Mn 90.62 Mn 429,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 429,000.00
Jun 30, 2026 429,000.00
Mar 31, 2026 492,000.00
Mar 31, 2026 492,000.00
Sep 30, 2025 1.12 Mn
Sep 30, 2025 1.12 Mn
Sep 30, 2024 270,000.00
Sep 30, 2024 270,000.00
Sep 30, 2023 260,000.00
Sep 30, 2023 260,000.00
Mar 31, 2023 33,000.00
Mar 31, 2023 33,000.00
Sep 30, 2022 33,000.00
Sep 30, 2022 33,000.00
Jun 30, 2022 13,000.00
Jun 30, 2022 13,000.00
Mar 31, 2022 9,000.00
Mar 31, 2022 9,000.00
Mar 31, 2020 13,000.00
Mar 31, 2020 13,000.00